Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPHC.L Regulatory News (PHC)

  • There is currently no data for PHC

Partnership

15 Feb 2007 09:04

Plant Health Care PLC15 February 2007 15 February 2007 PLANT HEALTH CARE FORMS PARTNERSHIP WITH AMERICAN SOYBEAN ASSOCIATION Plant Health Care Inc, a wholly owned subsidiary of Plant Health Care plc("Plant Health Care") and The American Soybean Association ("ASA") announce the2007 "N-Hibit Partnership" field trail programme that will evaluate PlantHealth Care's N-Hibit Seed Treatment, as a tool to lower Soyabean Cyst Nematode(SCN) and improve soybean plant health, during the 2007 growing season. The ASA represents a significant majority of the US soybean growers who plantedsome 75 million acres of soybeans in the US last year. N-Hibit is a dry material that is not a restricted use product. It is easy toapply, has an excellent safety profile and leaves no residuals in the water,soil or on plants. University field research has shown that N-Hibit reduces SCN eggs significantly.Other replicated and commercial research trails have also shown that N-Hibitincreases root and plant growth and increases soybean yield by about 6.5 percent per acre. The active ingredient in N-Hibit and other Harp-N-Tek products is harpinprotein, which is produced by disease causing bacteria that attack plants.Harp-N-Tek products do not contain pathogens, but cause the plant to respond asthough being attacked. Harpin proteins do not enter the plant. They bind withthe plant's external harpin protein receptors, which are present on seed, aswell as foliage. This turns on the plant's natural self defence and growthsystems. Then the harpin proteins harmlessly disintegrate ASA Vice President, Rob Joslin said: "ASA views this field trial program as anopportunity for its members to maximize soybean yield and profitability, andreduce the threat of SCN damage. We believe soybean growers will want to conducttheir own on-farm trials to determine results with N-Hibit on a commercial scaleunder their own growing conditions and management systems to help document theperformance of this seed treatment." John Brady CEO of Plant Health Care said: "We are delighted to be working withthe ASA on the Field Trail Programme for N-Hibit, as it will show soybeangrowers across the US that this product is highly effective and can help themincrease yield per acre and hence their profits. This is the best introductionto the soybean industry and as a result of this association we fully expectsignificant penetration into this huge market by 2008/2009". For further information contact: Plant Health Care plcJohn Brady, CEO; phone: +1 603 525 3702E-Mail: jabrady@planthealthcare.com Tavistock ComunicationsJeremy Carey/Matt Ridsdale, phone: +44 20 7920 3150E-Mail: jcarey@tavistock.co.uk, mridsdale@tavistock.co.uk Notes to Editors: About Plant Health Care:Plant Health Care plc ("PHC") is a leading provider of natural products forplants and soil. Established in 1995 in Pittsburgh (Pennsylvania) in the UnitedStates, PHC currently has approximately 70 employees and has operations in theUS, Mexico, UK, Spain, and the Netherlands. The Company listed on the AIM marketof the London Stock Exchange in July 2004. Ticker symbol is PHC. This information is provided by RNS The company news service from the London Stock Exchange
Date   Source Headline
29th Nov 201312:12 pmRNSDirector's Shareholding
25th Nov 20133:15 pmRNSDivestment of non-core subsidiary
18th Oct 20135:00 pmRNSTR-1 Notification of Major Interest in Shares
30th Sep 20135:00 pmRNSTotal Voting Rights
23rd Sep 201310:30 amRNSDirector/PDMR Shareholding
19th Sep 20137:00 amRNSAppointment of Adviser
18th Sep 20133:15 pmRNSDirector/PDMR Shareholding
16th Sep 20137:03 amRNSDirectorate Change
16th Sep 20137:00 amRNSHalf Yearly Report
19th Aug 20132:30 pmRNSBlocklisting Interim Review
30th Jul 20137:01 amRNSUpdate on Harpin
30th Jul 20137:00 amRNSPHC announces plans for Harpin seed treatment
22nd Jul 201311:00 amRNSPHC hires Glen Donald as VP Business Development
19th Jul 20137:00 amRNSHead Office Relocation,Research Facility Expansion
15th Jul 20135:15 pmRNSDirector/PDMR Shareholding
5th Jul 20137:00 amRNSUpdate on CISX Listing
3rd Jul 20137:00 amRNSNew Long-Term Incentive Plan and Grant of Awards
7th Jun 20134:15 pmRNSDirectorate Change
31st May 201311:30 amRNSTotal Voting Rights
21st May 201312:00 pmRNSHarpin Granted Federal Registration in Mexico
10th May 20134:45 pmRNSDirector/PDMR Shareholding
9th May 20131:20 pmRNSDirectorate Change
9th May 20131:20 pmRNSResult of AGM
7th May 201310:00 amRNSDirector/PDMR Shareholding
3rd May 20137:00 amRNSDirector/PDMR Shareholding
1st May 20137:00 amRNSDirector/PDMR Shareholding
1st May 20137:00 amRNSTotal Voting Rights
25th Apr 20137:00 amRNSPHC and Arysta LifeScience sign license agreement
19th Apr 20133:30 pmRNSTR-1 Notification of Major Interest in Shares
18th Apr 20133:33 pmRNSTR-1 Notification of Major Interest in Shares
18th Apr 20133:31 pmRNSTR-1 Notification of Major Interest in Shares
18th Apr 20133:31 pmRNSTR-1 Notification of Major Interest in Shares
16th Apr 20138:23 amRNSRe. Investment
15th Apr 20131:30 pmRNSResult of General Meeting
8th Apr 20135:45 pmRNSPublication of Annual Report and Notice of AGM
2nd Apr 20137:00 amRNSConfirmation of Board Changes
27th Mar 20137:00 amRNSPosting of Circular to Shareholders
26th Mar 20134:19 pmRNSBoard Changes
26th Mar 20134:19 pmRNSPlacing and Subscription
26th Mar 20134:18 pmRNSFinal Results
20th Mar 201311:35 amRNSPHC reaches milestone agreement with Germains
11th Mar 20137:00 amRNSMarket Update
19th Feb 20135:45 pmRNSBlock Listing Six-Monthly Return
24th Jan 20139:30 amRNSHarpin field trials results
18th Jan 20135:00 pmRNSNotification of Major Interest in Shares
10th Jan 201312:45 pmRNSTrading Update
31st Dec 201212:25 pmRNSTotal Voting Rights
30th Nov 201211:45 amRNSTotal Voting Rights
2nd Nov 201212:15 pmRNSNotification of Major Interest in Shares
23rd Oct 20127:00 amRNSNotification of Major Interest in Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.